Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.

WW International, known as WeightWatchers, saw its stock soar on new of its new compounded GLP-1 offering. But analysts say that's only a short-term solution to its ailing business.

The novel GLP-1 receptor agonists will likely reduce the need for CABG and improve surgical outcomes, several argue.

A voguish — and often daunting — problem can plague people who have experienced recent and relatively rapid weight loss.

Ozempic seems to be the hot topic on everyone’s lips right now, thanks to the wave of celebs who’ve admitted to using it to ...

Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...

WW stock popped after announcing a new compounded semaglutide product to benefit from the current shortage of weight loss ...

The drug combines semaglutide, the active ingredient in Wegovy ... REDEFINE1 tests cagrisema against a placebo and Wegovy, measuring weight loss over 68 weeks in about 3,400 people. Cagrisema’s ...

In a new interview with People, the 76-year-old Oscar winner that she lost 80 pounds over the past seven years through diet ...

Popular weight-loss medications including Ozempic and Wegovy contain a drug that seems to decrease cravings for food and ...

With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...

Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...